Fibrate Therapy

Fibrate Therapy is a pharmacotherapeutic approach within lipid-lowering interventions that specifically utilizes fibrate-class drugs to reduce triglyceride levels and elevate high-density lipoprotein cholesterol by activating peroxisome proliferator-activated receptor alpha.

242

Publications

16.7K

Citations

1.2K

Authors

485

Institutions

Publications per year

2017–2026

31

Authors

1.2K

  1. BS
    Bart Staels

    Institut Pasteur de Lille, France

    13 publications · 2.2K citations

    13

    h-index

  2. JF
    Jean‐Charles Fruchart

    Institut Pasteur de Lille, France

    7 publications · 881 citations

    7

    h-index

  3. JC
    Juan C. Laguna

    Universitat de Barcelona, Spain

    6 publications · 154 citations

    6

    h-index

  4. ÉB
    Éric Bruckert

    Sorbonne Université, France

    5 publications · 275 citations

    5

    h-index

  5. MM
    Manuel Merlos

    Uriach (Spain), Spain

    5 publications · 132 citations

    5

    h-index

1–5 of 1.2K

Venues

  1. PubMed

    Repository · 15 publications · 473 citations

    13

    h-index

  2. Atherosclerosis

    7 publications · 253 citations

    7

    h-index

  3. British Journal of Pharmacology

    BJP · 6 publications · 159 citations

    6

    h-index

  4. PLoS ONE

    6 publications · 148 citations

    6

    h-index

  5. Journal of Biological Chemistry

    JBC · 5 publications · 1.3K citations

    5

    h-index

1–5